Goldman Sachs on Friday lowered its price target for medical group Dr. Sulaiman Al Habib Medical Services Group (SASE:4013) to 275 Saudi riyals from 315 riyals, while keeping its neutral rating.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)